A sodium-glucose co-transporter 2 inhibitor empagliflozin prevents abnormality of circadian rhythm of blood pressure in salt-treated obese rats.
| Image |  |
|---|---|
| Description | scientific article published on 28 January 2016 |
| Author/s |
author: Hiroaki Ogata Asadur Rahman |
| Publication date | January 28, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |